WebStock Price Forecast The 4 analysts offering 12-month price forecasts for Gain Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 4.00. WebBETHESDA, Md., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric binding sites and creating small molecule treatments, today announced that Matthias ...
Did you know?
WebApr 6, 2024 · A high-level overview of Gain Therapeutics, Inc. (GANX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … Web2 days ago · GlobeNewswire. BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. ( Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of C. Evan Ballantyne as the Company’s Chief …
Web1 day ago · News; Brokers; More; Get started. News flow. Gain Therapeutics Appoints C. Evan Ballantyne As Chief Financial Officer. Apr 12, 2024 20:33 UTC. AGEN G GANX. Agenus Inc AGEN: GAIN THERAPEUTICS APPOINTS C. EVAN BALLANTYNE AS CHIEF FINANCIAL OFFICER. GAIN THERAPEUTICS INC - BALLANTYNE SUCCEEDS … WebFeb 27, 2024 · GANX Gain Therapeutics Inc Gain Therapeutics Presents New Preclinical Data from its Gaucher Disease Program at the 19th Annual WORLDSymposium BETHESDA, Md., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain', or the 'Company'), a biotechnology company transforming drug discovery …
WebA. The latest price target for Gain Therapeutics ( NASDAQ: GANX) was reported by Chardan Capital on Monday, March 27, 2024. The analyst firm set a price target for 5.75 expecting GANX to rise to ... WebMay 19, 2024 · Of the seven analysts that rated the stock, six have rated it Buy. A $38.86 consensus price target represents an 88.3% increase from its last closing price of $20.64. Gain Therapeutics, Inc. GANX develops various therapeutics to treat diseases caused by protein misfolding. Its primary focus is on rare genetic diseases and neurological disorders.
WebMar 17, 2024 · Gain Therapeutics Inc (GANX) stock is flat 0.11% while the S&P 500 is lower by -0.92% as of 1:31 PM on Friday, Mar 17. GANX is unmoved $0.00 from the …
WebFind the latest Gain Therapeutics, Inc. (GANX) stock quote, history, news and other vital information to help you with your stock trading and investing. dr. elizabeth byerly charleston scWebMar 23, 2024 · March 23, 2024 - 4:05 pm. Company expects completion of IND-enabling studies of GT-02287 in H1 2024; Submission of dossier to start Phase 1 clinical trial of GT-02287 in GBA1 Parkinson’s Disease expected by mid-year 2024 dr elizabeth canelasWebFind the latest GAN Limited (GAN) stock quote, history, news and other vital information to help you with your stock trading and investing. dr elizabeth byron west palm beach flWebMar 30, 2024 · Weaker technical forecast for Gain Therapeutics, Inc. as stock downgraded to Hold/Accumulate. (Updated on Mar 30, 2024) Buy or Hold candidate since 2024-03-13 Gain 14.04% PDF. The Gain Therapeutics, Inc. stock price fell by -2.28% on the last day (Thursday, 30th Mar 2024) from $4.82 to $4.71. During the last trading day the stock … english grammar for dummies bookWebApr 11, 2024 · According to 10 analysts, the average rating for GANX stock is "Buy." The 12-month stock price forecast is $9.12, which is an increase of 102.67% from the latest … english grammar for dummies 2nd editionWeb1 day ago · Gain Therapeutics, Inc. BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery ... dr elizabeth carson paWebFind the latest Gain Therapeutics, Inc. (GANX) stock quote, history, news and other vital information to help you with your stock trading and investing. Interactive Chart for Gain Therapeutics, Inc. (GANX), analyze all the data with a … Find the latest Gain Therapeutics, Inc. (GANX) stock discussion in Yahoo … Discover historical prices for GANX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Gain Therapeutics, Inc. (GANX), including … Get the detailed quarterly/annual income statement for Gain Therapeutics, Inc. … See the company profile for Gain Therapeutics, Inc. (GANX) including … Holder Shares Date Reported % Out Value; Fidelity Extended Market Index Fund: … See Gain Therapeutics, Inc. (GANX) stock analyst estimates, including earnings … View the basic GANX option chain and compare options of Gain Therapeutics, … Get the latest Gain Therapeutics, Inc. (GANX) stock news and headlines to … dr elizabeth carter boise idaho dds